Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
957.80
726.44
517.24
484.14
441.75
339.08
223.81
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
957.80
726.44
517.24
484.14
441.75
339.08
223.81
Raw Material Cost
96.80
45.73
10.17
11.95
11.69
11.34
12.38
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
473.46
402.47
369.09
403.22
397.52
333.89
271.71
Other Expenses
30.32
35.16
36.16
23.94
26.63
24.04
18.72
Total Expenditure (Excl Depreciation)
873.52
799.82
740.83
654.58
675.54
585.62
471.25
Operating Profit (PBDIT) excl Other Income
84.3
-73.4
-223.6
-170.39999999999998
-233.79999999999998
-246.5
-247.39999999999998
Other Income
173.80
22.34
10.15
2.92
5.61
12.16
3.51
Operating Profit (PBDIT)
273.96
-45.48
-211.42
-164.18
-225.24
-231.62
-240.93
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Items
0.00
0.00
0.00
0.00
-52.80
0.00
0.00
Gross Profit (PBDT)
860.99
680.71
507.07
472.19
430.07
327.73
211.43
Depreciation
15.88
5.55
2.03
3.34
2.93
2.77
3.00
Profit Before Tax
258.07
-51.04
-213.44
-167.52
-280.97
-234.38
-243.94
Tax
31.62
10.25
2.53
0.35
0.61
0.88
1.26
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
226.45
-61.29
-215.97
-167.87
-281.58
-235.26
-245.19
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
226.45
-61.29
-215.97
-167.87
-281.58
-235.26
-245.19
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
226.45
-61.29
-215.97
-167.87
-281.58
-235.26
-245.19
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
732.79
431.75
400.41
540.89
627.01
699.13
479.08
Earnings per share (EPS)
1.36
-0.37
-1.34
-1.05
-1.79
-1.6
-1.94
Diluted Earnings per share
1.36
-0.37
-1.34
-1.05
-1.79
-1.6
-1.94
Operating Profit Margin (Excl OI)
8.8%
-10.1%
-43.23%
-35.2%
-52.92%
-72.71%
-110.56%
Gross Profit Margin
28.6%
-6.26%
-40.87%
-33.91%
-62.94%
-68.31%
-107.65%
PAT Margin
23.64%
-8.44%
-41.76%
-34.67%
-63.74%
-69.38%
-109.56%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 31.86% vs 40.45% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is 469.49% vs 71.62% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 247.79% vs 69.40% in Dec 2023
Interest
No Interest in the last few periods
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has improved from Dec 2023
Compare Annual Results Of ACADIA Pharmaceuticals, Inc. With
Figures in Million
Consolidate Annual Results
Change(USD)
Change(%)
Net Sales
957.80
363.71
594.09
163.34%
Other Operating Income
0.00
0.00
0.00
Total Operating income
957.80
363.71
594.09
163.34%
Raw Material Cost
96.80
90.79
6.01
6.62%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
84.91
-84.91
-100.00%
Selling and Distribution Expenses
473.46
461.12
12.34
2.68%
Other Expenses
30.32
51.35
-21.03
-40.95%
Total Expenditure (Excl Depreciation)
873.52
1,150.28
-276.76
-24.06%
Operating Profit (PBDIT) excl Other Income
84.28
-786.57
870.85
110.71%
Other Income
173.80
53.34
120.46
225.83%
Operating Profit (PBDIT)
273.96
-722.22
996.18
137.93%
Interest
0.00
84.91
-84.91
-100.00%
Exceptional Items
0.00
-91.92
91.92
100.00%
Gross Profit (PBDT)
860.99
272.91
588.08
215.48%
Depreciation
15.88
11.01
4.87
44.23%
Profit Before Tax
258.07
-910.07
1,168.14
128.36%
Tax
31.62
3.71
27.91
752.29%
Provisions and contingencies
0
0
0.00
Profit After Tax
226.45
-913.77
1,140.22
124.78%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
226.45
-913.77
1,140.22
124.78%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
226.45
-913.77
1,140.22
124.78%
Equity Capital
0
0
0.00
Face Value
0.00
0.01
0.00
Reserves
732.79
285.38
447.41
156.78%
Earnings per share (EPS)
1.36
-5.57
6.93
124.42%
Diluted Earnings per share
1.36
-5.57
6.93
124.42%
Operating Profit Margin (Excl OI)
8.80%
-216.26%
0.00
225.06%
Gross Profit Margin
28.60%
-247.19%
0.00
275.79%
PAT Margin
23.64%
-251.24%
0.00
274.88%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 95.78 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 31.86% vs 40.45% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 22.65 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 469.49% vs 71.62% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 10.02 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 247.79% vs 69.40% in Dec 2023
Annual - Interest
No Interest in the last few periods
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 8.80%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has improved from Dec 2023






